Teva Pharmaceutical shares have rebounded from lows, driven by debt reduction. Check out why I rate TEVA stock as Strong Buy.

Teva Pharmaceutical (NYSE:TEVA) announced that it will divest Teva-Takeda, its business venture in Japan, to JKI ...

Teva Pharmaceutical Industries Ltd. (TEVA) announced that it will divest Teva-Takeda, its business venture in Japan, to JKI Co., Ltd.

Teva entered into an agreement with JKI Co., Ltd. (“JKI”) established by the fund managed and operated by private equity firm J-Will Partners ...

Shares in Teva Pharmaceutical Industries (NYSE: TEVA) closed more than 5% higher on Wednesday. The Israeli drugmaker earlier ...

Teva Pharmaceutical Industries has presented positive data from its Phase 3 SPACE study, demonstrating the efficacy and ...

Teva Pharmaceutical Industries has reported positive outcomes from its multicentre Phase III SPACE trial of Ajovy ...